Viewing Study NCT02105324



Ignite Creation Date: 2024-05-06 @ 2:42 AM
Last Modification Date: 2024-10-26 @ 11:22 AM
Study NCT ID: NCT02105324
Status: COMPLETED
Last Update Posted: 2017-10-20
First Post: 2014-04-02

Brief Title: The Summer Camp Study 2 Blood Glucose Control With a Bi-Hormonal Endocrine Pancreas
Sponsor: Massachusetts General Hospital
Organization: Massachusetts General Hospital

Study Overview

Official Title: The Summer Camp Study 2 Outpatient Automated Blood Glucose Control With a Bi-Hormonal Bionic Endocrine Pancreas in a Pediatric Population Ages 6-11 at the Clara Barton Diabetes Camps
Status: COMPLETED
Status Verified Date: 2017-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study will test the hypothesis that a wearable automated bionic pancreas system that automatically delivers both insulin and glucagon can improve glycemic control vs usual care for young people with type 1 diabetes ages 6-11 years old in a diabetes camp environment
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None